REGADENOSON
NDC 16729-477, REGADENOSON, injection, solution, from Accord Healthcare Inc..
- Product NDC
- 16729-477
- Status
- Listed
- Labeler
- Accord Healthcare Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213236
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-477-31 | 16729047731 | 5 mL in 1 SYRINGE, GLASS (16729-477-31) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=16729-477
Use it
Look up 16729-477 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-477 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-477. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.